It's really too late for this go-round but hopeful
Post# of 72440
A paltry $1B of Barda money could have had a dozen of these nightmare scenario drugs tested and ready to go on the shelves, Brilacidin included. This is a case where the capital markets failed to incentivize the development of these kinds of drugs.
Now we'll spend trillions in stimulus trying to buoy and recover from this decimation when a couple billion dollars of research and production could have significantly blunted the impact of this virus.
This is a failure across multiple US administrations and the world. It will be a costly lesson both in dollars and lives. Hopefully we can rebound quickly and take the lesson to heart.